Login / Signup

Expanding the evidence for managing metformin poisoning to support decision-making.

Darren M RobertsMarc Ghannoum
Published in: Clinical toxicology (Philadelphia, Pa.) (2023)
Case-based decision-making is always necessary, but in general, we continue to follow the Extracorporeal Treatments in Poisoning Workgroup criteria because a convincing reason for changing these has not yet been presented. This includes the use of intermittent hemodialysis where possible, particularly in cases of severe poisoning. For patients with less severe poisoning or when intermittent hemodialysis is not readily available, it is reasonable to trial continuous modalities with careful observation for deterioration.
Keyphrases
  • decision making
  • peritoneal dialysis
  • early onset
  • clinical trial
  • high intensity
  • randomized controlled trial
  • drug induced
  • phase iii
  • open label
  • phase ii